{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(9)"],"submitter":["Fratoni AJ"],"pubmed_abstract":["Patients hospitalized with coronavirus disease 2019 (COVID-19) often receive empiric antibiotic coverage. Procalcitonin (PCT) is a biomarker with Food and Drug Administration-approved guidance cutoffs for antibiotic use in lower respiratory tract infections. Herein we describe the implementation and impact of a pharmacist-managed PCT monitoring program in hospitalized patients with COVID-19. In this quasi-experimental, single-center, retrospective study of a prospective antimicrobial stewardship pharmacist-managed program, inpatients who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction positive were reviewed during weekday working hours and evaluated for appropriateness of antibiotic treatment by utilizing the PCT biomarker. As needed, the infecti"],"journal":["Open forum infectious diseases"],"pagination":["ofac468"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9494375"],"repository":["biostudies-literature"],"pubmed_title":["Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization."],"pmcid":["PMC9494375"],"pubmed_authors":["Nicolau DP","Fratoni AJ","Kois AK","Linder KE","Colmerauer JL","Kuti JL"],"additional_accession":[]},"is_claimable":false,"name":"Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.","description":"Patients hospitalized with coronavirus disease 2019 (COVID-19) often receive empiric antibiotic coverage. Procalcitonin (PCT) is a biomarker with Food and Drug Administration-approved guidance cutoffs for antibiotic use in lower respiratory tract infections. Herein we describe the implementation and impact of a pharmacist-managed PCT monitoring program in hospitalized patients with COVID-19. In this quasi-experimental, single-center, retrospective study of a prospective antimicrobial stewardship pharmacist-managed program, inpatients who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction positive were reviewed during weekday working hours and evaluated for appropriateness of antibiotic treatment by utilizing the PCT biomarker. As needed, the infecti","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-27T03:03:18.72Z","creation":"2025-02-19T02:24:47.532Z"},"accession":"S-EPMC9494375","cross_references":{"pubmed":["36176570"],"doi":["10.1093/ofid/ofac468"]}}